Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Comment by Firepokeron Mar 09, 2024 7:50am
74 Views
Post# 35924238

RE:MDMA larger piece of TRIP pie???

RE:MDMA larger piece of TRIP pie??? my conclusions from his answers to questions at the AMA regarding TRIP...

Nick was approached by TRIP for assistance  because of Nick''s and Pharmala highly regarded reputation ...it is a cash payment only ...plus to jointly develop a product that MDMA wants to be the exclusive sales agent in the future...Nick has the contacts and Cortexa...what's not to like...as for a larger role with TRIP itself, which was my own musings earlier...I did not get a feel for that. ...just Nick seeing an important opportunity to create a new high quality product with TRIP for the for medical industry..
here is a snippet from Nick''s response to a question at the AMA on CEO group..

" - Our discussions with customers have led us to believe that there is a market for a GMP, medicinal psilocybin product that comes from a natural source. We haven’t found one in the market that fits our needs, or the regulatory requirements that Health Canada or TGA have."

Pharmala is a game changer...





<< Previous
Bullboard Posts
Next >>